175 related articles for article (PubMed ID: 15648953)
1. CYC-202 Cyclacel.
Guzi T
Curr Opin Investig Drugs; 2004 Dec; 5(12):1311-8. PubMed ID: 15648953
[TBL] [Abstract][Full Text] [Related]
2. MS-209 Schering.
Robert J
Curr Opin Investig Drugs; 2004 Dec; 5(12):1340-7. PubMed ID: 15648956
[TBL] [Abstract][Full Text] [Related]
3. CC-5013 (Celgene).
Mitsiades CS; Mitsiades N
Curr Opin Investig Drugs; 2004 Jun; 5(6):635-47. PubMed ID: 15242253
[TBL] [Abstract][Full Text] [Related]
4. Epothilone D (Kosan/Roche).
Kolman A
Curr Opin Investig Drugs; 2004 Jun; 5(6):657-67. PubMed ID: 15242255
[TBL] [Abstract][Full Text] [Related]
5. BMS-247550 Bristol-Myers Squibb/GBF.
Lin N; Brakora K; Seiden M
Curr Opin Investig Drugs; 2003 Jun; 4(6):746-56. PubMed ID: 12901236
[TBL] [Abstract][Full Text] [Related]
6. AE-941 (AEterna).
Dredge K
Curr Opin Investig Drugs; 2004 Jun; 5(6):668-77. PubMed ID: 15242256
[TBL] [Abstract][Full Text] [Related]
7. OSI-461 (OSI).
Galmarini CM
Curr Opin Investig Drugs; 2004 Jun; 5(6):648-56. PubMed ID: 15242254
[TBL] [Abstract][Full Text] [Related]
8. Technology evaluation: cantuzumab mertansine, ImmunoGen.
Smith SV
Curr Opin Mol Ther; 2004 Dec; 6(6):666-74. PubMed ID: 15663331
[TBL] [Abstract][Full Text] [Related]
9. Diflomotecan. Ipsen.
Osheroff N
IDrugs; 2004 Mar; 7(3):257-63. PubMed ID: 15011101
[No Abstract] [Full Text] [Related]
10. Technology evaluation: Kahalalide F, PharmaMar.
Hamann MT
Curr Opin Mol Ther; 2004 Dec; 6(6):657-65. PubMed ID: 15663330
[TBL] [Abstract][Full Text] [Related]
11. Learning from exceptional drug responders.
Mullard A
Nat Rev Drug Discov; 2014 Jun; 13(6):401-2. PubMed ID: 24875081
[No Abstract] [Full Text] [Related]
12. Su-11248 Sugen.
Sakamoto KM
Curr Opin Investig Drugs; 2004 Dec; 5(12):1329-39. PubMed ID: 15648955
[TBL] [Abstract][Full Text] [Related]
13. BAY-43-9006 Bayer/Onyx.
Lee JT; McCubrey JA
Curr Opin Investig Drugs; 2003 Jun; 4(6):757-63. PubMed ID: 12901237
[TBL] [Abstract][Full Text] [Related]
14. 27th Annual JPMorgan Healthcare Conference--BioCryst and Emergent Biosolutions.
Croasdell G; Gale S
IDrugs; 2009 Mar; 12(3):149-51. PubMed ID: 19333891
[No Abstract] [Full Text] [Related]
15. 27th Annual JPMorgan Healthcare Conference--Antisoma and Keryx Biopharmaceuticals.
Croasdell G; Gale S
IDrugs; 2009 Mar; 12(3):152-4. PubMed ID: 19333892
[No Abstract] [Full Text] [Related]
16. American society of clinical oncology - 45th annual meeting. Part 2.
Lakeram M; Kibble A
IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155
[No Abstract] [Full Text] [Related]
17. American society of clinical oncology - 45th annual meeting. Part 1.
Gale S
IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154
[No Abstract] [Full Text] [Related]
18. ZD-6126 AstraZeneca.
Soltau J; Drevs J
IDrugs; 2004 Apr; 7(4):380-7. PubMed ID: 15057644
[TBL] [Abstract][Full Text] [Related]
19. Drug discovery conference 2008. Small-Molecule Drug Discovery: From Early Stage to the Clinic.
Terrett NK
IDrugs; 2008 Mar; 11(3):164-8. PubMed ID: 18311648
[No Abstract] [Full Text] [Related]
20. TG-4010 Transgene.
Cohen S; Kaufman HL
Curr Opin Investig Drugs; 2004 Dec; 5(12):1319-28. PubMed ID: 15648954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]